Sunmax Biotechnology Market Cap

Sunmax Biotechnology has a market cap or net worth of 21.68 billion as of December 5, 2025. Its market cap has increased by 41.64% in one year.

Market Cap

21.68B

Enterprise Value

21.06B

Revenue

2.00B

Ranking

n/a

PE Ratio

30.27

Stock Price

398.00

Market Cap Chart

Since January 25, 2010, Sunmax Biotechnology's market cap has increased from 1.49B to 21.68B, an increase of 1,357.64%. That is a compound annual growth rate of 18.39%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	21.68B	42.14%
Dec 30, 2024	15.25B	37.25%
Dec 29, 2023	11.11B	50.00%
Dec 30, 2022	7.41B	64.65%
Dec 30, 2021	4.50B	2.61%
Dec 31, 2020	4.38B	0.37%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	258.22B
PharmaEssentia	191.58B
Lotus Pharmaceutical	78.89B
Bora Pharmaceuticals Co., LTD.	65.31B
Lin BioScience	34.87B
Oneness Biotech	34.78B
Lumosa Therapeutics	32.51B
Center Laboratories	27.88B

Market Cap Rankings